Patient shaking doctor's hand and imagery of two healthcare products.

SIMPLIFY THE DIAGNOSTIC JOURNEY

Two simple tests can transform how you evaluate esophageal motility disorders and GERD:

  • Endoflip™ impedance planimetry system
  • Bravo™ calibration-free reflux testing system

DOWNLOAD BROCHURE

Older male sitting on front step of home.

DIFFICULT TO DIAGNOSE

CHALLENGING TO MANAGE

Esophageal disease patients can have similar symptoms — but their diseases may be different. This means tests aren't always conclusive and treatment isn't always effective:

  • Up to 50 percent of endoscopies for predominant esophageal symptoms are negative1-3
  • One in three patients referred with ongoing symptoms while using PPIs doesn’t have GERD4

MOVE BEYOND SYMPTOMS WITH TWO SIMPLE TESTS

Our solutions help you objectively evaluate the root cause of esophageal motility disorders and GERD.

  • Endoflip™ measures pressure and dimensions in real-time to evaluate suspected esophageal motility disorders.
  • The Bravo™ calibration-free reflux testing system improves your workflow — simply pair and place to start assessing acid reflux.

View Brochure To Learn More
Female doctor holding tablet talks to older female patient.

YOUR PARTNER IN ESOPHAGEAL CARE

Learn how our comprehensive portfolio can help you care for patients across the care continuum — from GERD to Barrett's esophagus.

Explore Content

SPEAK WITH A REPRESENTATIVE

For additional information about the EndoflipTM or BravoTM systems, complete a brief form to speak directly with a Medtronic sales representative.

REQUEST INFORMATION

CAUTIONS AND RISKS

Caution: Federal law restricts these devices to sale by or on the order of a licensed healthcare practitioner. Rx only.

Risk Information: Similar to most procedures, the products featured here have inherent procedure risks associated. Please refer to the individual product user manuals for detailed information.


1

Laine, Goldmann et al. In the clinic: gastroesophageal reflux disease. Annals of Internal Medicine. 2008 Aug 5; ITC2: 1-16.

2

Kahrilas PJ. Gastroesophageal reflux disease. N Engl J Med. 2008; 359: 1700-7.            

3

Ronkainen et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005; 129: 1825-1831.

4

Herregods, T. V. K., et al. Patients with refractory reflux symptoms often do not have GERD: Neurogastroenterology & Motility. 2015; 27(9): 1267-1273.